| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.051 | 0.3 |